Easy Access and Express Report Delivery Service
Epigenetic Market, Global Outlook and Forecast 2024-2030
Report ID
47338
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
64
Editor's Rating
-
Report Details
The global Epigenetic market is projected to reach US$ 11230 million by 2030. Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence. This report contains market size and forecasts of Epigenetic in Global, including the following market information: Global Epigenetic Market Size 2025-2030, ($ millions) The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Epigenetic Market, by Type, 2025-2030 ($ millions) Global Epigenetic Market Segment Percentages, by Type Reagents Kits Instruments Enzymes Services Global Epigenetic Market, by Application, 2025-2030 ($ millions) Global Epigenetic Market Segment Percentages, by Application Academic Research Institutes Biotechnology Companies Biopharmaceutical Companies Diagnostic Companies Global Epigenetic Market, By Region and Country, 2025-2030 ($ Millions) Global Epigenetic Market Segment Percentages, by region and country United States Europe Asia China Rest of World Competitor Analysis The report also provides analysis of leading market participants including: Further, the report presents profiles of competitors in the market, key players include: Illumina Qiagen Abcam Merck & Co Sigma-Aldrich New England Biolabs Thermo Fisher Scientific Diagenode Active Motif Roche Diagnostics Eisai Novartis -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Epigenetic Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Epigenetic Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Epigenetic Overall Market Size 2.1 Global Epigenetic Market Size: 2024 VS 2030 2.2 Global Epigenetic Market Size, Prospects & Forecasts: 2024-2030 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Key Epigenetic Players in Global Market 3.2 Global Companies Epigenetic Product & Technology 4 Epigenetic Companies Profiles 4.1 Illumina 4.1.1 Illumina Company Summary 4.1.2 Illumina Business Overview 4.1.3 Illumina Epigenetic Product Offerings & Technology 4.1.4 Illumina Epigenetic R&D, and Plans 4.2 Qiagen 4.2.1 Qiagen Company Summary 4.2.2 Qiagen Business Overview 4.2.3 Qiagen Epigenetic Product Offerings & Technology 4.2.4 Qiagen Epigenetic R&D, and Plans 4.3 Abcam 4.3.1 Abcam Company Summary 4.3.2 Abcam Business Overview 4.3.3 Abcam Epigenetic Product Offerings & Technology 4.3.4 Abcam Epigenetic R&D, and Plans 4.4 Merck & Co 4.4.1 Merck & Co Company Summary 4.4.2 Merck & Co Business Overview 4.4.3 Merck & Co Epigenetic Product Offerings & Technology 4.4.4 Merck & Co Epigenetic R&D, and Plans 4.5 Sigma-Aldrich 4.5.1 Sigma-Aldrich Company Summary 4.5.2 Sigma-Aldrich Business Overview 4.5.3 Sigma-Aldrich Epigenetic Product Offerings & Technology 4.5.4 Sigma-Aldrich Epigenetic R&D, and Plans 4.6 New England Biolabs 4.6.1 New England Biolabs Company Summary 4.6.2 New England Biolabs Business Overview 4.6.3 New England Biolabs Epigenetic Product Offerings & Technology 4.6.4 New England Biolabs Epigenetic R&D, and Plans 4.7 Thermo Fisher Scientific 4.7.1 Thermo Fisher Scientific Company Summary 4.7.2 Thermo Fisher Scientific Business Overview 4.7.3 Thermo Fisher Scientific Epigenetic Product Offerings & Technology 4.7.4 Thermo Fisher Scientific Epigenetic R&D, and Plans 4.8 Diagenode 4.8.1 Diagenode Company Summary 4.8.2 Diagenode Business Overview 4.8.3 Diagenode Epigenetic Product Offerings & Technology 4.8.4 Diagenode Epigenetic R&D, and Plans 4.9 Active Motif 4.9.1 Active Motif Company Summary 4.9.2 Active Motif Business Overview 4.9.3 Active Motif Epigenetic Product Offerings & Technology 4.9.4 Active Motif Epigenetic R&D, and Plans 4.10 Roche Diagnostics 4.10.1 Roche Diagnostics Company Summary 4.10.2 Roche Diagnostics Business Overview 4.10.3 Roche Diagnostics Epigenetic Product Offerings & Technology 4.10.4 Roche Diagnostics Epigenetic R&D, and Plans 4.11 Eisai 4.11.1 Eisai Company Summary 4.11.2 Eisai Business Overview 4.11.3 Eisai Epigenetic Product Offerings & Technology 4.11.4 Eisai Epigenetic R&D, and Plans 4.12 Novartis 4.12.1 Novartis Company Summary 4.12.2 Novartis Business Overview 4.12.3 Novartis Epigenetic Product Offerings & Technology 4.12.4 Novartis Epigenetic R&D, and Plans 5 Sights by Region 5.1 By Region - Global Epigenetic Market Size, 2025 & 2030 5.2 By Region - Global Epigenetic Revenue, (2025-2030) 5.3 United States 5.3.1 Key Players of Epigenetic in United States 5.3.2 United States Epigenetic Development Current Situation and Forecast 5.4 Europe 5.4.1 Key Players of Epigenetic in Europe 5.4.2 Europe Epigenetic Development Current Situation and Forecast 5.5 China 5.5.1 Key Players of Epigenetic in China 5.5.2 China Epigenetic Development Current Situation and Forecast 5.6 Rest of World 6 Sights by Product 6.1 By Type - Global Epigenetic Market Size Markets, 2025 & 2030 6.2 Reagents 6.3 Kits 6.4 Instruments 6.5 Enzymes 6.6 Services 7 Sights by Application 7.1 By Application - Global Epigenetic Market Size, 2025 & 2030 7.2 Academic Research Institutes 7.3 Biotechnology Companies 7.4 Biopharmaceutical Companies 7.5 Diagnostic Companies 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
